Holly Dolejsi of Robins Kaplan Appointed Farxiga MDL Co-Lead Counsel

We’re pleased to share the news that “Judge Lorna G. Schofield of the U.S. District Court for the Southern District of New York has appointed Robins Kaplan LLP® attorney Holly Dolejsi as co-lead counsel in multidistrict litigation (MDL) involving the diabetes drug Farxiga. Dolejsi will also serve as one of seven attorneys on the Plaintiffs’ Steering Committee